Why Is Coty (COTY) Down 10.6% Since Last Earnings Report?

Coty shares have fallen 10.6% since its latest results, after fiscal Q4 2026 adjusted EPS loss of $0.02 was wider than the $0.01 consensus loss despite revenue of $1.27B exceeding the $1.19B estimate. Underlying performance weakened: LFL revenue fell 1%, gross margin declined 140bps to 60.9%, adjusted EBITDA dropped 26% to $93.6M, and Consumer Beauty EBITDA fell 67%. For Q1 fiscal 2027, management forecasts a low- to mid-single-digit LFL sales decline, 50-100bps gross-margin contraction and a low-teens EBITDA decline; consensus estimates have been cut 9.76%. Improved free cash flow of $72.6M and lower net debt of $2.91B offer offsets, alongside $400M in expected Gucci Beauty license-transition payments.

Analysis

COTY's problem is not demand alone but unfavorable operating leverage: modest volume shortfalls are flowing disproportionately into margin because the cost base and inventory burden were built for a higher shipment run-rate. That makes the next 1-3 months vulnerable to another estimate-reset cycle, particularly if retailer orders remain conservative rather than merely end-consumer sell-through weak. At roughly 3.4x leverage, sustained EBITDA pressure matters more for equity value than the incremental debt reduction suggests; each turn of multiple compression or EBITDA disappointment has an amplified impact on residual equity.

The Gucci transition removes a high-recognition asset from the medium-term portfolio and shifts COTY's investment case toward execution in less proven replacement brands and cost reduction. KER gains strategic control and greater long-term brand consistency, but should incur launch, distribution and marketing investment before any licensing economics are recaptured; this is not a near-term earnings catalyst for KER. Competitive read-through is selectively constructive for EL, LVMUY and PUIG.MC: prestige players with owned brands and stronger balance sheets can absorb marketing investment and retail inventory normalization better than a license-dependent, leveraged peer.

The contrarian case is that the equity may already discount a weak transition year, while cash conversion creates a tangible deleveraging floor and U.S. mass-market sell-out could stabilize faster than shipments. That is insufficient for a directional long before evidence emerges: COTY needs sequential gross-margin stabilization and a narrowing gap between sell-out and reported sales. A confirmed margin recovery in the second half would be the catalyst for multiple expansion over 6-18 months; another guidance reduction or leverage failing to decline would invalidate the value thesis.

Key Decisions for Investors

• Maintain a 1-3 month underweight/short bias on COTY into the next results only on rallies; use a 7-10% stop from entry. The intended payoff is 15-20% downside if EBITDA estimates reset again, while an early cost-save or sell-out inflection is the principal squeeze risk.
• Express the relative-quality trade as long EL / short COTY in approximately beta-neutral dollars for 3-6 months. EL has its own China and margin risks, but the pair isolates COTY's licensing-transition, leverage and fixed-cost exposure; close if COTY demonstrates two consecutive quarters of gross-margin improvement or EL's organic-sales trajectory deteriorates materially.
• Do not buy COTY solely on headline free-cash-flow yield. Upgrade to a tactical long only after management demonstrates sequential improvement in gross margin and reiterates full-year cash generation while net leverage falls below 3.0x; target a 20-30% rerating over 6-12 months with a stop on a renewed EBITDA-guide cut.
• Watch KER rather than chase it on the licensing change. Consider a 12-18 month long only if management quantifies Gucci Beauty's post-transition investment and profit path; the key risk is that reclaiming control raises brand spending faster than it captures incremental revenue.